Sabrina Runbeck Business Logo in PNG

The Provider’s Edge

Increase Productivity Increase Profit

I didn’t go into medicine to be a cardiac surgeon with Dr. Thomas MacGillivray

I didn’t go into medicine to be a cardiac surgeon with Dr. Thomas MacGillivray
WED, 01 JUL 2020 00:00:00 -0500 ◦ 38 MINUTES
Dr. Thomas E. MacGillivray, MD is a national top cardiothoracic surgeon currently working at Houston Methodist Hospital, the DeBakey Heart & Vascular center as the Chief of Cardiac Surgery and Thoracic Transplant Surgery, as well as the Jimmy Howell Endowed Chair in Cardiovascular Surgery. Previously, he was Co-Director of the Thoracic Aortic Center and Surgical Director of the Adult Congenital Heart Disease Program at Massachusetts General Hospital in Boston. Dr. MacGillivray currently serves as the Society’s Treasurer-Elect; he previously was Chair of the Council on Education and Member Service for the Society of Thoracic Surgery.

If you want to connect with Dr. MacGillivray visit https://www.houstonmethodist.org/heart-vascular/

Are you a busy and ambitious healthcare professional who is looking to advance in your career without feeling overwhelmed, undervalued, or underappreciated? Then sign up for our FREE 7-days online summit.
Reserve your seat at SabrinaRunbeck.com/summit

Have a topic or question you'd like to see covered on the show? Send an email to Sabrina@SabrinaRunbeck.com or message Sabrina on Instagram, Facebook, or LinkedIn @SabrinaRunbeck.

Recent Post

Why So Many Good Startups Get Ignored—And What Smart Investors Are Doing About It

By Sabrina | 05/23/2025

Why So Many Good Startups Get Ignored And What Smart Investors Are Doing About It Every year, investors collectively spend…

Why Brook.AI’s Wraparound Model Is a Scalable Investment Bet

By Sabrina | 05/16/2025

Remote Care as a Service: Why Brook.AI’s Wraparound Model Is a Scalable Investment Bet Healthcare systems aren’t short on tools.…

Why Operational Risk Is the Silent Killer of HealthTech ROI

By Sabrina | 05/10/2025

Why Operational Risk Is the Silent Killer of HealthTech ROI A brilliant product means nothing if it crumbles under operational…

Where Investors See ROI: When Access Meets Precision

By Sabrina | 05/02/2025

Where Investors See ROI: When Access Meets Precision Investors don’t want another dashboard-they want clear proof their capital fuels patient…

How Women in HealthTech Are Building Their Own Funding Pathways

By Sabrina | 04/28/2025

How Women in HealthTech Are Building Their Own Funding Pathways Less than 3% of venture capital dollars go to women-led…

Tech Equity Is the Missing Link in Health Equity

By Sabrina | 04/18/2025

Burnout, Bias & Bottlenecks: Why Data Efficiency Is the Next Big Bet in HealthTech Burnout, bias, and bottlenecks-three red flags…

How to Spot HealthTech Startups That Prevent Costly Readmissions

By Sabrina | 04/13/2025

How to Spot HealthTech Startups That Prevent Costly Readmissions Discover what separates HealthTech startups that scale from those that stall.…

Why Great HealthTech Ideas Stall: A Due Diligence Framework for Evaluating Execution Teams

By Sabrina | 04/13/2025

Why Great HealthTech Ideas Stall: A Due Diligence Framework for Evaluating Execution Teams Why do HealthTech startups stall even with…

Why Investors Don’t “Get” Your Pitch — And How to Fix It

By Sabrina | 03/30/2025

Why Investors Don’t “Get” Your Pitch And How to Fix It You’ve built a unicorn. Or at least, you know…

6 Months to 2 Days: Slashing Specialist Wait Times for Healthcare Tech Founders

By Sabrina | 03/21/2025

6 Months to 2 Days: Slashing Specialist Wait Times for Healthcare Tech Founders “We reduced as a case study in…